Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?
Schema description coverage is 100%, so both parameters are already documented, and the description only restates the 10-label ceiling already present in the 'max' schema. Baseline 3 applies since the description adds no new meaning about drug-name matching behavior (e.g., exact vs. partial match).
Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.